» Articles » PMID: 17510774

Pancreatic VIPomas: Subject Review and One Institutional Experience

Overview
Specialty Gastroenterology
Date 2007 May 19
PMID 17510774
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

VIPomas are rare pancreatic endocrine tumors associated with a well-defined clinical syndrome characterized by watery diarrhea, hypokalemia, and metabolic acidosis. The objective of this study was to review a single institution's experience with VIPomas, as well as to review the English literature. A retrospective review of the Johns Hopkins pancreatic database revealed four cases of VIPoma, with three patients being male. All patients presented with watery diarrhea, hypokalemia, hypercalcemia, and acidosis. All patients had no family history of multiple endocrine neoplasia. Computed tomography revealed the primary pancreatic tumor in all patients, with three tumors located in the tail of the pancreas. One tumor involved the entire pancreas. Computed tomography and/or octreotide radionuclide scans identified hepatic metastasis in three patients. Mean serum vasoactive intestinal polypeptide levels were 683 pg/ml (range 293 to 1,500 pg/ml). All patients underwent resection of the pancreatic primary tumor. Two patients also had simultaneous liver resections. All patients had evidence of malignancy as defined by the presence of metastatic lymph nodes and/or hepatic metastases. Two patients had complete resolution of symptoms after surgical resection. One patient required radioablation of liver metastases and adjuvant octreotide therapy for control of symptoms. One patient died of progressive metastatic disease 96 months after surgery, whereas the other three remain alive. Extended, meaningful survival can be achieved for VIPoma patients, combining an aggressive surgical approach with additional strategies for treatment of unresected disease.

Citing Articles

Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms.

Albers M, Sevcik M, Wiese D, Manoharan J, Rinke A, Jesinghaus M Sci Rep. 2024; 14(1):18507.

PMID: 39122816 PMC: 11316089. DOI: 10.1038/s41598-024-68290-1.


Pancreatic Vasoactive Intestinal Peptide-Producing Tumor as a Rare Cause of Acute Diarrhea and Severe Hypokalemia.

Giampatzis V, Kotsiari C, Bostantzis P, Chrisoulidou A, Fotiadou A, Loti S J Med Cases. 2023; 14(9-10):307-316.

PMID: 37868325 PMC: 10586331. DOI: 10.14740/jmc4141.


spp. utilize the type 3 secretion system to manipulate the VIP/VPAC2 signaling and promote colonization and persistence of the three classical in the lower respiratory tract.

First N, Pedreira-Lopez J, San-Silvestre M, Parrish K, Lu X, Gestal M Front Cell Infect Microbiol. 2023; 13:1111502.

PMID: 37065208 PMC: 10090565. DOI: 10.3389/fcimb.2023.1111502.


Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.

Cai Y, Liu Z, Jiang L, Ma D, Zhou Z, Ju H Front Endocrinol (Lausanne). 2022; 13:871830.

PMID: 35937823 PMC: 9350735. DOI: 10.3389/fendo.2022.871830.


Vasoactive intestinal peptide secreting tumour: An overview.

Una Cidon E World J Gastrointest Oncol. 2022; 14(4):808-819.

PMID: 35582098 PMC: 9048535. DOI: 10.4251/wjgo.v14.i4.808.


References
1.
Yanagi H, Kusunoki M, Sakanoue Y, Shoji Y, Yamamura T, Murai M . Vipoma of the pancreas complicating ulcerative colitis. Am J Gastroenterol. 1991; 86(8):1066-9. View

2.
Antonelli A, Gambuzza C, Bertoni F, BASCHIERI L . Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome. J Endocrinol Invest. 1993; 16(1):57-9. DOI: 10.1007/BF03345831. View

3.
Holst J, Fahrenkrug J, Knuhtsen S, Jensen S, Poulsen S, NIELSEN O . Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion. Regul Pept. 1984; 8(3):245-59. DOI: 10.1016/0167-0115(84)90066-1. View

4.
Peng S, Li J, Liu Y, Fang H, Wu Y, Peng C . Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. Pancreas. 2004; 28(1):93-7. DOI: 10.1097/00006676-200401000-00015. View

5.
Drivas I, Mansberg R, Roberts J . VIPoma: a rare cause of a pancreatic mass. Clin Nucl Med. 2004; 29(3):201-3. DOI: 10.1097/01.rlu.0000114016.24359.d2. View